InvestSMART

Sonic Healthcare Limited (ASX: SHL) - ETF Exposure

Current share price for SHL : $18.530 0.04 (0.22%)+

Sonic Healthcare (SHL) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is involved in provision of medical diagnostic services and the provision of administrative services and facilities to medical practitioners.

SHL General Information +

ASX Code SHL
Website http://sonichealthcare.com
Industry/Sector Health Care Services
Market Cap ($M) 9,158
SHL Share Price $18.530
Day High $18.590
Day Low $18.310
Last Close $18.570
SHL Share Price Movement $0.04 ( 0.22% )
Prices as at 16:40, 19 Oct 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to SHL

As a significant Australian company by market capitalisation, SHL is held across 38 ETFs spanning strategies that include health care services exposure . Its weighting in those funds means performance can have an outsized influence - when SHL moves, funds like IHD, FAIR, VSO, ZYAU and MVW that hold it can move with it.

For more concentrated exposure, ETFs such as IHD (iShares S&P/ASX High Dividend Opportunities ETF) allocate about 2.1% to SHL , while the average exposure across all 38 ETFs that hold it is around 0.7% .

Top ETF holdings

Last updated: ETF data and holdings as at 19 October 2026

Own SHL directly or through an ETF?

How does holding Sonic Healthcare Limited (SHL) shares directly compare to ETFs that include it?

SHL Direct
IHD
ASX
FAIR
ASX
VSO
ASX
ZYAU
ASX
MVW
ASX
Holdings 1 company 56 holdings 83 holdings 204 holdings 59 holdings 76 holdings
SHL Weight 100% 2.1% 1.9% 1.6% 1.3% 1.3%
Diversification Single Stock Broad Broad Broad Broad Broad
Annual Cost Brokerage only 0.23% p.a. 0.49% p.a. 0.3% p.a. 0.24% p.a. 0.35% p.a.
Approx. Yield 5.2% 4.21% 3.13% 4.94% 4.58% 3.37%
Star Ratings - starstarstarstar starstarstarstar starstarstarstar starstarstar starstarstarstarstar

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not SHL's direct yield. Annual cost uses each ETF's MER.

SHL Exposure on $10,000 investment

How a $10,000 investment in Sonic Healthcare Limited (SHL) one week ago compares with ETFs that hold it.

Security Investment type Current price 7-day price movement Dollar change Value today
Sonic Healthcare Limited (SHL) Direct share $18.530 -0.64% -$64 $9,936
iShares S&P/ASX High Dividend Opportunities ETF (IHD) Equity - Australia Strategy $16.600 1.59% +$159 $10,159
BetaShares Australian Sustainability Leaders ETF (FAIR) Equity - Australia Strategy $18.490 0.82% +$82 $10,082
Vanguard MSCI Australian Small Companies Index ETF (VSO) Equity - Australia Small/Mid Cap $70.770 -1.59% -$159 $9,841
Global X S&P/ASX 200 High Dividend ETF (ZYAU) Equity - Australia Strategy $10.230 2.51% +$251 $10,251
VanEck Australian Equal Weight ETF (MVW) Equity - Australia $38.900 1.22% +$122 $10,122

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

Sonic Healthcare Limited (SHL) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
HFResult 63¢ 60% 2 Sep 2026 17 Sep 2026 - - -
Result 45¢ 60% 4 Mar 2026 19 Mar 2026 - - -
HFResult 63¢ 35% 3 Sep 2025 18 Sep 2025 - - -

See all dividends from Sonic Healthcare Limited (SHL) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Sonic Healthcare Limited (SHL) price-sensitive announcements

SHL - Financial and Operational Review - Year Ended 30 June 2026
Sonic Healthcare Limited reported a successful financial year ended 30 June 2026, with a 1
Sonic Healthcare Limited (SHL)
20 Aug 2026 | 9:23 AM
SHL - Media Release - Full Year Results to 30 June 2026
Sonic Healthcare Limited reported a robust financial performance for the fiscal year endin
Sonic Healthcare Limited (SHL)
20 Aug 2026 | 9:22 AM
SHL - Preliminary Final Report FY2026
Sonic Healthcare Limited's Preliminary Final Report for the financial year ending June 30,
Sonic Healthcare Limited (SHL)
20 Aug 2026 | 9:17 AM
SHL - CEO Presentation Half Year Results to 31 December 2025
Sonic Healthcare Limited reported its half-year results for the period ending 31 December
Sonic Healthcare Limited (SHL)
19 Feb 2026 | 8:50 AM

Sonic Healthcare Limited (SHL) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Sonic Healthcare Limited (SHL)
ORDINARY FULLY PAID
Health Care $9,158 Change of Director's Interest Notice 1 Oct 2026 5:24PM $18.610 $18.530 fallen by 0.43%
Sonic Healthcare Limited (SHL)
ORDINARY FULLY PAID
Health Care $9,158 Change of Director's Interest Notice 1 Oct 2026 5:22PM $18.610 $18.530 fallen by 0.43%
Sonic Healthcare Limited (SHL)
ORDINARY FULLY PAID
Health Care $9,158 Change of Registry Address Notification 25 Sep 2026 9:34AM $18.910 $18.530 fallen by 2.01%
Sonic Healthcare Limited (SHL)
ORDINARY FULLY PAID
Health Care $9,158 Appendix 4G 24 Sep 2026 5:37PM $18.910 $18.530 fallen by 2.01%
Sonic Healthcare Limited (SHL)
ORDINARY FULLY PAID
Health Care $9,158 Annual Report to shareholders 24 Sep 2026 5:32PM $18.910 $18.530 fallen by 2.01%
Sonic Healthcare Limited (SHL)
ORDINARY FULLY PAID
Health Care $9,158 Notification regarding unquoted securities - SHL 24 Sep 2026 5:27PM $18.910 $18.530 fallen by 2.01%

SHL Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2026F $601.94 $119.00 18.50% 23.88 109.00 3.84% 30.0%
2025F $507.92 $100.41 -1.70% 28.30 108.00 3.80% 30.0%
2024A $487.02 $102.10 -29.60% 29.37 106.00 3.54% 0.0%

SHL Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2024 A 2025 F 2026 F 2024 A 2025 F 2026 F 2024 A 2025 F 2026 F
Australian Clinical Labs Limited (ACL) $533M 0.0442 -0.0111 0.0428 15.1243 15.2941 14.6667 4.55% 4.55% 4.37%
Integral Diagnostics Limited (IDX) $789M 0.7037 0.0000 0.1877 16.1686 16.1686 13.6129 4.41% 3.55% 4.03%
Sonic Healthcare Limited (SHL) $9,178M 0.2969 -0.1774 0.1040 13.4196 16.3138 14.7768 5.82% 5.65% 5.95%

SHL Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.59 14.20 1.10 0.00
Market 0.65 15.60 1.56 1.20
Sector 0.74 21.70 1.82 2.47

SHL Directors

Name Position Start Date
Mr Christopher David Wilks Chief Financial Officer, Finance Director 5 Dec 1989
Mr Neville Mitchell Non-Executive Director 29 Sep 2017
Professor Suzanne Crowe Non-Executive Director 6 Apr 2020
Professor Christine Constance Bennett Non-Executive Director 26 Sep 2022
Ms Kathryn (Kate) Dianne Spargo Non-Executive Director 1 Jul 2010
Ms Nicola Wakefield Evans Non-Executive Director 10 Feb 2025
Dr Katharine Giles Non-Executive Director 26 Sep 2022
Mr James Pacey Newcombe Non-Executive Director 20 Nov 2025
Mr Mark Raymond Compton Non-Executive Director, Non-Executive Chairman 7 Oct 2014

Sonic Healthcare Limited (SHL) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
16 Oct 2025 WAKEFIELD EVANS, Nicola Buy Indirect Shares 2,500 $21.780 $54,450.000
15 Oct 2025 GILES, Katharine Buy Indirect Shares 1,000 $21.169 $21,169.200
3 Oct 2025 GILES, Katharine Buy Indirect Shares 1,000 $21.720 $21,720.000

See all changes in directors' interest & trades for Sonic Healthcare Limited (SHL) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

SHL Management

Name Position
Paul Joseph Alexander Company Secretary,Deputy Chief Financial Officer

SHL Calendar of Events

Date Event
23 September 2027 Report (Annual)
19 August 2027 Report (Prelim)
18 February 2027 Report (Interim)
19 November 2026 AGM

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.